The number of new COVID-19 cases increased again on Thursday while the number of patients hospitalized statewide and across the Valley continued to drop.
Search / 912 results found Showing: 1-10 of 912
THURSDAY, Jan. 27, 2022 (HealthDay News) -- In response to claims that a man was denied a heart transplant because he refused to get vaccinated against COVID-19, Brigham and Women's Hospital in Boston said Wednesday that its transplant policies mirror those used across the United States.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- An initial surge in antibody levels against the Omicron variant after a booster dose of the Moderna COVID vaccine wanes within six months, but the antibodies remained effective against it in lab tests, a new study finds.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot -- one that hones in on the highly contagious Omicron variant.
THURSDAY, Jan. 27, 2022 (HealthDay News) -- They've gotten some media headlines recently, but potential menstrual changes associated with getting a COVID vaccine are typically minor and temporary, two new international studies confirm.
RADNOR, Pa., Jan. 27, 2022 /PRNewswire/ -- NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce effective levels of neutralizing antibody against the Omicron variant of the SARS-CoV-2 virus.1 More importantly, many of the mutations (alterations) that cause the Omicron variant spike protein to differ from the spike protein of the original SARS-CoV-2 virus that causes COVID-19 have been identified in the spike protein of the BriLife vaccine. This natural evolution of the BriLife vaccine suggests that the vaccine may continue to evolve to address future Variants of Concern (VOCs). Unlike the current mRNA vaccines and attenuated virus vaccines, the BriLife vaccine is a live, viral vector vaccine in which the spike protein of the SARS-CoV-2 virus has been added to a benign virus, called VSV. A similar viral vector was used to create the successful, FDA-approved vaccine against Ebola virus.
CHARLESTON — West Virginia hospitals hit a new record of COVID patients Wednesday, climbing to 1,043, and it may get worse as hospitals have already reached capacity.